Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

French analysts' fury over government fee decision:

This article was originally published in Clinica

Executive Summary

The outgoing French government has rejected an agreement drawn up between three associations representing clinical analysts and the national healthcare insurer, CNAM, in a move that has provoked anger and frustration. The government is opposed to the fees increase in clinical analyses from E0.26 ($0.24) to E0.27 claiming that it would cost an additional E87.75 million to the national sickness insurance funds, an increase of 4.7% on current spending levels. The associations representing clinical analysts are furious, demanding to know what use agreements are if the government can simply overturn them. They hope, however, that the next government will be open to further discussion.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT066520

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel